MAPT and Alzheimer disease: In support of this, in a streptozotocin-induced AD–diabetes rat model [145] and in a mouse model overexpressing human tau (hTau) in the hippocampus, improved synaptic plasticity indicated by increased long-term potentiation (LTP) was reported after artemisinin and DHA treatment, respectively, with improved learning and memory tests.